TY - JOUR A1 - Wegner, Karl David A1 - Dussert, F. A1 - Truffier-Boutry, D. A1 - Benayad, A. A1 - Beal, D. A1 - Mattera, L. A1 - Ling, W. L. A1 - Carrière, M. A1 - Reiss, P. T1 - Influence of the Core/Shell Structure of Indium Phosphide Based Quantum Dots on Their Photostability and Cytotoxicity N2 - With the goal to improve their photostability, InP-based QDs are passivated with three types of inorganic shells, namely (i) a gradient ZnSexS1−x shell, (ii) an additional ZnS shell on top of the gradient shell with two different thicknesses (core/shell/shell, CSS), (iii) an alumina coating on top of ZnS. All three systems have photoluminescence Quantum yields (PLQY) > 50%and similar PL decay times (64–67 ns). To assess their photostability they are incorporated into a transparent poly (methyl methacrylate) (PMMA) matrix and exposed to continuous irradiation with simulated sunlight in a climate chamber. The alumina coated core/shell system exhibits the highest stability in terms of PLQY Retention as well as the lowest shift of the PL maximum and lowest increase of the PL linewidth, followed by the CSS QDs and finally the gradient shell system. By means of XPS studies we identify the degradation of the ZnS outer layer and concomitant xidation of the emissive InZnP core as the main origins of degradation in the gradient structure. These modifications do not occur in the case of the alumina-capped sample, which exhibits excellent chemical stability. The gradient shell and CSS systems could be transferred to the aqueous phase using surface ligand exchange with penicillamine. Cytotoxicity studies on human primary keratinocytes revealed that exposure for 24 h to 6.25–100 nM of QDs did not affect cell viability. However, a trend toward reduced cell proliferation is observed for higher concentrations of gradient shell and CSS QDs with a thin ZnS shell, while CSS QDs with a thicker ZnS shell do not exhibit any impact. KW - Indium phosphide KW - Quantum dots KW - Cytotoxicity KW - Photostability PY - 2019 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-494249 DO - https://doi.org/10.3389/fchem.2019.00466 VL - 7 SP - Article Number: 466 PB - Frontiers Media SA AN - OPUS4-49424 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Wegner, Karl David A1 - Moros, M. A1 - Castillo-Michel, H. A1 - Materra, L. A1 - Onorato, G. A1 - Ling, W. L. A1 - Reiss, P. A1 - Tortiglione, C. T1 - In Vivo Biotransformations of Indium Phosphide Quantum Dots Revealed by X‑Ray Microspectroscopy N2 - Many attempts have been made to synthesize cadmium-free quantum dots (QDs), using nontoxic materials, while preserving their unique optical properties. Despite impressive advances, gaps in knowledge of their intracellular fate, persistence, and excretion from the targeted cell or organism still exist, precluding clinical applications. In this study, we used a simple model organism (Hydra vulgaris) presenting a tissue grade of organization to determine the biodistribution of indium phosphide (InP)-based QDs by X-ray fluorescence imaging. By complementing elemental imaging with In L-edge X-ray absorption near edge structure, unique information on in situ chemical speciation was obtained. Unexpectedly, spectral profiles indicated the appearance of In−O species within the first hour post-treatment, suggesting a fast degradation of the InP QD core in vivo, induced mainly by carboxylate groups. Moreover, no significant difference in the behavior of bare core QDs and QDs capped with an inorganic Zn(Se,S) gradient shell was observed. The results paralleled those achieved by treating animals with an equivalent dose of indium salts, confirming the preferred bonding type of In3+ ions in Hydra tissues. In conclusion, by focusing on the chemical identity of indium along a 48 h long journey of QDs in Hydra, we describe a fast degradation process, in the absence of evident toxicity. These data pave the way to new paradigms to be considered in the biocompatibility assessment of QD-based biomedical applications, with greater emphasis on the dynamics of in vivo biotransformations, and suggest strategies to drive the design of future applied materials for nanotechnology-based diagnosis and therapeutics. KW - Indium phosphide KW - Quantum dots KW - Cytotoxicity KW - X-ray microspectroscopy PY - 2019 DO - https://doi.org/10.1021/acsami.9b15433 VL - 11 IS - 39 SP - 35630 EP - 35640 PB - ACS Publications AN - OPUS4-49425 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Kalot, G. A1 - Godard, A. A1 - Busser, B. A1 - Pliquett, J. A1 - Broekgaarden, M. A1 - Motto-Ros, V. A1 - Wegner, Karl David A1 - Resch-Genger, Ute A1 - Köster, U. A1 - Denat, F. A1 - Coll, J.-L. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications N2 - Boron neutron capture therapy (BNCT) is a radiotherapeutic modality based on the nuclear capture of slow neutrons by stable 10B atoms followed by charged particle Emission that inducing extensive damage on a very localized level (<10 um). To be effcient, a suffcient amount of 10B should accumulate in the tumor area while being almost cleared from the normal surroundings. A water-soluble aza-boron-dipyrromethene dyes (BODIPY) fluorophore was reported to strongly accumulate in the tumor area with high and BNCT compatible Tumor/Healthy Tissue ratios. The clinically used 10B-BSH (sodium borocaptate) was coupled to the water-soluble aza-BODIPY platform for enhanced 10B-BSH tumor vectorization. We demonstrated a strong uptake of the compound in tumor cells and determined its biodistribution in mice-bearing tumors. A model of chorioallantoic membrane-bearing glioblastoma xenograft was developed to evidence the BNCT potential of such compound, by subjecting it to slow neutrons. We demonstrated the Tumor accumulation of the compound in real-time using optical imaging and ex vivo using elemental imaging based on laser-induced breakdown spectroscopy. The tumor growth was significantly reduced as compared to BNCT with 10B-BSH. Altogether, the fluorescent aza-BODIPY/10B-BSH compound is able to vectorize and image the 10B-BSH in the tumor area, increasing its theranostic potential for effcient approach of BNCT. KW - Aza-BODIPY KW - SWIR KW - NIR-I KW - Theranostic KW - Boron compound KW - Optical imaging PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-512280 DO - https://doi.org/10.3390/cells9091953 VL - 9 IS - 9 SP - 1953 PB - MDPI AN - OPUS4-51228 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Pliquett, J. A1 - Busser, B. A1 - Le Guével, X. A1 - Wegner, Karl David A1 - Resch-Genger, Ute A1 - Russelin, Y. A1 - Coll, J.-L. A1 - Denat, F. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - Water-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II Imaging N2 - A simple NIR-II emitting water-soluble system has been developed and applied in vitro and in vivo. In vitro, the fluorophore quickly accumulated in 2D and 3D cell cultures and rapidly reached the tumor in rodents, showing high NIR-II contrast for up to 1 week. This very efficient probe possesses all the qualities necessary for translation to the clinic as well as for the development of NIR-II emitting materials. KW - Aza-BODIPY KW - NIR-II Imaging KW - In vivo imaging KW - organic dyes KW - SWIR KW - Cancer KW - Fluorescence PY - 2020 DO - https://doi.org/10.1021/acs.bioconjchem.0c00175 VL - 31 IS - 4 SP - 1088 EP - 1092 PB - ACS Publications AN - OPUS4-50695 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Privat, M. A1 - Bendellaa, M. A1 - Busser, B. A1 - Wegner, Karl David A1 - Denat, F. A1 - Le Guevel, X. A1 - Coll, J.-L. A1 - Paul, C. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer N2 - Using fluorescence-guided surgery (FGS) to cytoreductive surgery helps achieving complete resection of microscopic ovarian tumors. The use of visible and NIR-I fluorophores has led to beneficial results in clinical trials; however, involving NIR-II dyes seems to outperform those benefits due to the deeper tissue imaging and higher signal/noise ratio attained within the NIR-II optical window. In this context, we developed NIR-II emitting dyes targeting human epidermal growth factor receptor 2 (HER2)-positive ovarian tumors by coupling water-soluble NIR-II aza-BODIPY dyes to the FDA-approved anti-HER2 antibody, namely, trastuzumab. These bioconjugated NIR-II-emitting dyes displayed a prolonged stability in serum and a maintained affinity toward HER2 in vitro. We obtained selective targeting of HER2 positive tumors (SKOV-3) in vivo, with a favorable tumor accumulation. We demonstrated the fluorescence properties and the specific HER2 binding of the bioconjugated dyes in vivo and thus their potential for NIR-II FGS in the cancer setting. KW - NIR-II KW - Fluorescent dye KW - In vivo imaging KW - Ovarian cancer KW - Antibody conjuagtes KW - Bioimaging PY - 2023 DO - https://doi.org/10.1021/acs.jmedchem.3c00100 SN - 0022-2623 VL - 66 IS - 7 SP - 5185 EP - 5195 PB - ACS Publications AN - OPUS4-57293 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Holde, David A1 - Ubbelohde, L. A1 - Marcusson, J. T1 - Über die natürlich vorkommende Heptadecylsäure PY - 1905 VL - 23 IS - 1 SP - 36 EP - 44 PB - Springer CY - Berlin AN - OPUS4-13375 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Hakme, C. A1 - Stevenson, I. A1 - David, L. A1 - Boiteux, G. A1 - Seytre, G. A1 - Schönhals, Andreas T1 - Uniaxially stretched poly(ethylene naphthalene 2,6-dicarboxylate) films studied by broadband dielectric spectroscopy N2 - The thermal behaviors of amorphous PEN films uniaxially stretched above and below Tg have been characterized by Temperature Modulated DSC. When drawing is performed above Tg, the degree of crystallinity and the glass transition temperature Tg increase with increasing drawing ratio. PEN samples stretched below Tg are more crystalline than when stretched above Tg. Moreover the cold crystallization phenomenon disappears with drawing as a result of the mechanically induced crystallization. Broadband dielectric spectroscopy has also been used to study the influence of the orientation on the molecular mobility of PEN to gain insight into the microscopic origin of the relaxation processes in the transverse direction i.e. when the electric field is perpendicular to the stretching direction. Dielectric relaxation phenomena are thus discussed as a function of the microstructure (orientation, crystallinity). The α-relaxation dynamics associated with the glass transition are largely slowed down by the drawing process and the relaxation strength decreases. This can be related to a transformation of the amorphous phase into (i) crystalline, (ii) rigid amorphous fraction (RAF) and/or constrained amorphous phase with lower molecular mobility due to the crystallization induced by the orientation process. In contrast, the dynamics of the ß*-relaxation are apparently increased and the activation energy for the uniaxially stretched samples decreases compared to the unstretched isotropic amorphous state. If the ß*-relaxation is assigned to the presence of naphthalene aggregates, this leads to the conclusion that stretching is structurally altering the naphthalene aggregates (creation of defective aggregates that induces a higher molecular mobility) or orientation is selecting the faster motions active for ß*. The ß-relaxation which corresponds to more local motions implying reorientation of the ester groups seems to be broad and composed of two components as in the case of PET: the ß1- and ß2-relaxations. While the high frequency ß1-component relaxation strength is increasing significantly with the deformation below Tg, that of the ß2-process is more related to the presence of water. KW - Poly(ethylene 2,6-naphthalene-dicarboxylate) KW - Dielectric Relaxation Spectroscopy (DRS) KW - TMDSC PY - 2005 DO - https://doi.org/10.1016/j.jnoncrysol.2005.05.039 SN - 0022-3093 VL - 351 IS - 33-36 SP - 2742 EP - 2752 PB - North-Holland Publ. Co. CY - Amsterdam AN - OPUS4-10855 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Ewert, Uwe A1 - Redmer, Benrhard A1 - Schumacher, David A1 - Thiessenhusen, Kai-Uwe A1 - Bellon, Carsten A1 - Nicholson, P. I. A1 - Clarke, A. L. A1 - Finke-Härkönen, K.-P. T1 - X-ray tomographic in-service inspection of girth welds – the european project tomoweld N2 - The new standard ‘ISO 17636-2:2013: Non-destructive testing of welds — Radiographic testing — Part 2: X- and gamma-ray techniques with digital detectors’, defines the practice for radiographic inspection of welded pipes for manufacturing and in-service inspection. It is applied in Europe for inspections of pipe welds in nuclear power plants as well as in chemical plants and allows a faster inspection with digital detector arrays (DDA) than with film. Nevertheless, it does not allow the evaluation of the depth and shape of volumetric and planar indications. In 2001 a planar tomography scanner, TomoCAR, was introduced for mechanized radiographic testing (RT) inspection and non-destructive measurement of cross sections. The project TomoWELD is based on a new concept of the scan geometry, an enhanced GPU based reconstruction, and the application of a new generation of photon counting DDAs based on CdTe crystal CMOS hybrids. The new detector permits the selection of energy thresholds to obtain an optimum energy range and reduction of the influence of scattered radiation. The concept and first measurements are presented. Flaw depth and shape of volumetric and planar irregularities can be determined. T2 - QNDE 2014 CY - Boise, Idaho, USA DA - 20.07.2014 KW - X-ray imaging KW - Tomography KW - Engineering inspection KW - Radiography KW - Welded joints KW - Chemical plants PY - 2015 SN - 978-0-7354-1292-7 DO - https://doi.org/10.1063/1.4914650 SN - 0094-243X N1 - Geburtsname von Schumacher, David: Walter, D. - Birth name of Schumacher, David: Walter, D. VL - 1650 SP - 525 EP - 533 PB - American Institute of Physics AN - OPUS4-36581 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Kang, Y. A1 - Nack, L. M. A1 - Liu, Y. A1 - Qi, B. A1 - Huang, Y. A1 - Liu, Z. A1 - Chakraborty, I. A1 - Schulz, F. A1 - Ahmed, A. A. A. A1 - Poveda, M. C. A1 - Hafizi, F. A1 - Roy, S. A1 - Mutas, M. A1 - Holzapfel, M. A1 - Sanchez-Cano, C. A1 - Wegner, Karl David A1 - Feliu, N. A1 - Parak, W. J. T1 - Quantitative considerations about the size dependence of cellular entry and excretion of colloidal nanoparticles for different cell types N2 - Most studies about the interaction of nanoparticles (NPs) with cells have focused on how the physicochemical properties of NPs will influence their uptake by cells. However, much less is known about their potential excretion from cells. However, to control and manipulate the number of NPs in a cell, both cellular uptake and excretion must be studied quantitatively. Monitoring the intracellular and extracellular amount of NPs over time (after residual noninternalized NPs have been removed) enables one to disentangle the influences of cell proliferation and exocytosis, the major pathways for the reduction of NPs per cell. Proliferation depends on the type of cells, while exocytosis depends in addition on properties of the NPs, such as their size. Examples are given herein on the role of these two different processes for different cells and NPs. KW - Cell proliferation KW - Exocytosis KW - Gold nanoparticles KW - Quantum dots KW - Fluorescence KW - Uptake studies PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-543476 DO - https://doi.org/10.1007/s40828-021-00159-6 SN - 2199-3793 VL - 8 IS - 1 SP - 1 EP - 8 PB - Springer CY - Berlin AN - OPUS4-54347 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Bhuckory, S. A1 - Wegner, Karl David A1 - Qiu, X. A1 - Wu, Y.T. A1 - Jennings, T. L. A1 - Incamps, A. A1 - Hildebrandt, N. T1 - Triplexed CEA-NSE-PSA Immunoassay Using Time-Gated Terbium-to-Quantum Dot FRET N2 - Time-gated Förster resonance energy transfer (TG-FRET) between Tb complexes and luminescent semiconductor quantum dots (QDs) provides highly advantageous photophysical properties for multiplexed biosensing. Multiplexed Tb-to-QD FRET immunoassays possess a large potential for in vitro diagnostics, but their performance is often insufficient for their application under clinical conditions. Here, we developed a homogeneous TG-FRET immunoassay for the quantification of carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), and prostatespecific antigen (PSA) from a single serum sample by multiplexed Tb-to-QD FRET. Tb–IgG antibody donor conjugates were combined with compact QD-F(ab’)2 antibody acceptor conjugates with three different QDs emitting at 605, 650, and 705 nm. Upon antibody–antigen–antibody Sandwich complex formation, the QD acceptors were sensitized via FRET from Tb, and the FRET ratios of QD and Tb TG luminescence intensities increased specifically with increasing antigen concentrations. Although limits of detection (LoDs: 3.6 ng/mL CEA, 3.5 ng/mL NSE, and 0.3 ng/mL PSA) for the triplexed assay were slightly higher compared to the single-antigen assays, they were still in a clinically relevant concentration range and could be quantified in 50 μL serum samples on a B·R·A·H·M·S KRYPTOR Compact PLUS clinical immunoassay plate reader. The simultaneous quantification of CEA, NSE, and PSA at different concentrations from the same serum sample demonstrated actual multiplexing Tb-to-QD FRET immunoassays and the potential of this technology for translation into clinical diagnostics. KW - Lanthanides KW - Nanoparticles KW - Biosensing KW - Multiplexing KW - FRET KW - Fluorescence KW - PSA KW - NSE KW - CEA PY - 2020 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-512290 DO - https://doi.org/10.3390/molecules25163679 VL - 25 IS - 16 SP - 3679 PB - MDPI AN - OPUS4-51229 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -